These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10741711)

  • 1. In vivo and in vitro ovarian carcinoma growth inhibition by a phosphatidylinositol 3-kinase inhibitor (LY294002).
    Hu L; Zaloudek C; Mills GB; Gray J; Jaffe RB
    Clin Cancer Res; 2000 Mar; 6(3):880-6. PubMed ID: 10741711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of phosphatidylinositol 3'-kinase increases efficacy of paclitaxel in in vitro and in vivo ovarian cancer models.
    Hu L; Hofmann J; Lu Y; Mills GB; Jaffe RB
    Cancer Res; 2002 Feb; 62(4):1087-92. PubMed ID: 11861387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphatidylinositol 3-kinase mediates angiogenesis and vascular permeability associated with ovarian carcinoma.
    Hu L; Hofmann J; Jaffe RB
    Clin Cancer Res; 2005 Nov; 11(22):8208-12. PubMed ID: 16299254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibitory effect of tirapazamine combined with phosphatidylinositol 3-kinase inhibitor LY294002 to ovarian cancer cells].
    Ren Y; Zha X; Zhang GN
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(17):1204-6. PubMed ID: 17686243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth inhibition of human malignant glioma cells induced by the PI3-K-specific inhibitor.
    Shingu T; Yamada K; Hara N; Moritake K; Osago H; Terashima M; Uemura T; Yamasaki T; Tsuchiya M
    J Neurosurg; 2003 Jan; 98(1):154-61. PubMed ID: 12546364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of phosphatidylinositol-3 kinase in epithelial ovarian carcinoma].
    Zhang PN; Sun H
    Zhonghua Fu Chan Ke Za Zhi; 2007 Mar; 42(3):196-200. PubMed ID: 17537308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of phosphatidylinositol 3-kinase/Akt and histone deacetylase activity induces apoptosis in non-small cell lung cancer in vitro and in vivo.
    Denlinger CE; Rundall BK; Jones DR
    J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1422-9. PubMed ID: 16256798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor immunoneutralization plus Paclitaxel markedly reduces tumor burden and ascites in athymic mouse model of ovarian cancer.
    Hu L; Hofmann J; Zaloudek C; Ferrara N; Hamilton T; Jaffe RB
    Am J Pathol; 2002 Nov; 161(5):1917-24. PubMed ID: 12414537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of inhibitor of nuclear factor-kappaB phosphorylation increases the efficacy of paclitaxel in in vitro and in vivo ovarian cancer models.
    Mabuchi S; Ohmichi M; Nishio Y; Hayasaka T; Kimura A; Ohta T; Kawagoe J; Takahashi K; Yada-Hashimoto N; Seino-Noda H; Sakata M; Motoyama T; Kurachi H; Testa JR; Tasaka K; Murata Y
    Clin Cancer Res; 2004 Nov; 10(22):7645-54. PubMed ID: 15569997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The targeting of phosphoinositide-3 kinase attenuates pulmonary metastatic tumor growth following laparotomy.
    Coffey JC; Wang JH; Bouchier-Hayes D; Cotter TG; Redmond HP
    Ann Surg; 2006 Feb; 243(2):250-6. PubMed ID: 16432359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PIK3CA is implicated as an oncogene in ovarian cancer.
    Shayesteh L; Lu Y; Kuo WL; Baldocchi R; Godfrey T; Collins C; Pinkel D; Powell B; Mills GB; Gray JW
    Nat Genet; 1999 Jan; 21(1):99-102. PubMed ID: 9916799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of triptolide as an adjunct chemotherapy for ovarian cancer.
    Westfall SD; Nilsson EE; Skinner MK
    Chemotherapy; 2008; 54(1):67-76. PubMed ID: 18073474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LY294002-mediated inhibition of phosphatidylinositol 3-kinase activity triggers growth inhibition and apoptosis in CD40-triggered Ramos-Burkitt lymphoma B cells.
    Curnock AP; Knox KA
    Cell Immunol; 1998 Aug; 187(2):77-87. PubMed ID: 9732695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphatidylinositol 3-kinase inhibitors are a triple threat to ovarian cancer.
    Parsons R
    Clin Cancer Res; 2005 Nov; 11(22):7965-6. PubMed ID: 16299225
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of combined therapy of LY294002 and SN50 on nude mice model with gastric cancer].
    Sun JL; Zhu BS; Gong W; Zhang P; Yu LY; Zhao K; Xing CG
    Zhonghua Wei Chang Wai Ke Za Zhi; 2011 May; 14(5):364-7. PubMed ID: 21614693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of phosphatidylinositol 3-kinase sensitizes ovarian cancer cells to carboplatin and allows adjunct chemotherapy treatment.
    Westfall SD; Skinner MK
    Mol Cancer Ther; 2005 Nov; 4(11):1764-71. PubMed ID: 16275998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphatidylinositol 3-kinase inhibition by LY294002 radiosensitizes human cervical cancer cell lines.
    Lee CM; Fuhrman CB; Planelles V; Peltier MR; Gaffney DK; Soisson AP; Dodson MK; Tolley HD; Green CL; Zempolich KA
    Clin Cancer Res; 2006 Jan; 12(1):250-6. PubMed ID: 16397049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphatidylinositol 3-kinase inhibitor(LY294002) induces apoptosis of human nasopharyngeal carcinoma in vitro and in vivo.
    Jiang H; Fan D; Zhou G; Li X; Deng H
    J Exp Clin Cancer Res; 2010 Apr; 29(1):34. PubMed ID: 20412566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An inhibitor of PI3-K differentially affects proliferation and IL-6 protein secretion in normal and leukemic myeloid cells depending on the stage of differentiation.
    Birkenkamp KU; Esselink MT; Kruijer W; Vellenga E
    Exp Hematol; 2000 Nov; 28(11):1239-49. PubMed ID: 11063872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The phosphatidylinositol 3-kinase inhibitor LY294002 binds the estrogen receptor and inhibits 17beta-estradiol-induced transcriptional activity of an estrogen sensitive reporter gene.
    Pasapera Limón AM; Herrera-Muñoz J; Gutiérrez-Sagal R; Ulloa-Aguirre A
    Mol Cell Endocrinol; 2003 Feb; 200(1-2):199-202. PubMed ID: 12644312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.